In collaboration with our international partner, cell line and process development for affordable medicines are developed. PMBP takes advantage in world class CDMO services, striving to build strong process development for designed and optimized processes, in an attempt to generate recombinant glycoproteins and therapeutic antibodies in highly productive, efficient manufacturing processes. With these collaborations, we are able to deliver site-specific gene integration into the production cell lines.